Trial Profile
Galantamine Treatment for Nonfluent Aphasia in Stroke Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 May 2010
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Aphasia
- Focus Therapeutic Use
- 29 May 2010 New trial record